ADVANCED PHARMACOLOGY OR PRESCRIBERS 1STEDITION BY LUO K AYINGO TEST BANK|2024 UPDATE

ADVANCED PHARMACOLOGY FOR
F F FF




PRESCRIBERS 1ST EDITION BY LUO K
F F F F F




AYINGO TEST BANK | 2024 UPDATE
F F F F F

, Table of Contents
F F

ChapterF 1:FAnFIntroductionFtoFEvidence-BasedFClinicalF PracticeFGuidelines .............................................. 3
ChapterF2:FPharmacokineticsF /Chapter3:FPharmacodynamics ..................................................................... 13
Chapter4:FPharmacogeneticsF andFPharmacogenomics ................................................................................ 25
ChapterF 5:FPharmacologyFAcrossFtheFLifeFSpan ......................................................................................... 30
ChapterF 6:FDrug-TherapyFPrescribingFinFSpecialFPopulations .................................................................... 36
ChapterF 7:FDrugFDevelopmentF andFApproval ............................................................................................. 45
ChapterF8-ChapterF10:FFoundationsFofFPrescriptionFWritingFChapterF9:FResponsibleControlled-
SubstanceFPrescribingFChapterF10:FAntibioticFStewardship......................................................................... 51
ChapterF 11:FAppliedFCalculationsFforF Prescribing ...................................................................................... 58
ChapterF12-:FPromotingFAdherenceFWithFPharmacotherapyFII:FSystem-SpecificFandFPatient-
FocusedFPrescribingFChapterF13:FPharmacotherapyFforFEar,FNose,FMouth,FandThroatFConditionsF/ChapterF
14:FPharmacotherapyFforFEyeFConditions .................................................................................................... 67
ChapterF15:FPharmacotherapyFforF SkinFConditions .................................................................................... 74
ChapterF 16:FPharmacotherapyFforF NeurologicF Conditions .......................................................................... 81
ChapterF 17:FPharmacotherapyFforF CardiovascularF Conditions ................................................................... 94
ChapterF 18:FPharmacotherapyFforF RespiratoryFConditions ....................................................................... 106
ChapterF19:FPharmacotherapyFforFGastrointestinalFConditionsFandFConditionsFRequiringNutritionalFSuppo
rt ................................................................................................................................................................ 117
ChapterF 20:FPharmacotherapyFforF GenitourinaryFConditions ................................................................... 128
ChapterF21:FPharmacotherapyFforF Renal,FAcid–Base,F Fluid,FandFElectrolyteFDisorders .......................... 133
ChapterF 22:FPharmacotherapyFforF MusculoskeletalFandFRheumatologicFConditions ............................... 146
ChapterF23:FTherapeuticF ApplicationsF ofFImmunologyFandFVaccines...................................................... 158
ChapterF 24:FPharmacotherapyFforF EndocrineFDisorders ........................................................................... 163
ChapterF25:FPharmacotherapyFforFHematologicFDisorders ....................................................................... 174
ChapterF 26:FHematology/OncologyFandFSupportiveFCareFforFtheFNononcologist..................................... 190
ChapterF 27:FPharmacotherapyF RelatedFtoFWomen’sFHealthFConditions................................................... 196
ChapterF28:FPharmacotherapyFRelatedFtoFMen’sF HealthFConditions ........................................................ 211
ChapterF 29:FPharmacotherapyFRelatedFtoFTransgenderF Care .................................................................... 217
ChapterF 30:FAntimicrobialFPharmacotherapy ............................................................................................ 224
ChapterF 31:FAntiretroviralFPharmacotherapy ............................................................................................ 235
ChapterF32:FPsychopharmacologyFandFIntegrativeFHealth:FCombinedFTreatmentFofPsychiatricFandFNeuroc
ognitiveF Conditions.................................................................................................................................... 247
ChapterF 33:FPharmacotherapyFforFPainFManagement ............................................................................... 257
ChapterF34:FSubstanceFUseFDisorderF III:FHealthFPromotionFandFMaintenance......................................... 267
ChapterF35:FOver-the-CounterF Medications .............................................................................................. 283
ChapterF36:FPharmacotherapyFforFObesity ................................................................................................ 291

,ChapterF1:FAnFIntroductionFtoFEvidence-BasedFClinicalFPracticeFGuidelines
MULTIPLEFCHOICE

• WhatFisFtheFprimaryFpurposeF ofFtheFnursingF assessment?

A. IdentifyingF underlyingF pathologicF conditions
B. AssistingF theFphysicianFinFidentifyingFmedicalF conditions
C. DeterminingF theFpatientsFmentalFstatus
D. ExploringF patientF responsesFtoF healthF problems


ANS:FD

AFnursingFassessmentFisFdoneFtoFidentifyFtheFpatientsFresponseFtoFhealthFpro
blems.FDuringFtheFnursingFassessmentFphase,FaFcomprehensiveFinformationF
baseFisFdevelopedFthroughFaFphysicalFexamination,FnursingFhistory,Fmedicat
ionFhistory,FandFprofessionalFobservation.FIdentifyingFunderlyingFpathologi
cFconditionsFandFassistingFtheFphysicianFinFidentifyingFmedicalFconditionsFi
sFnotFpartFofFtheFnursingFprocess.FDeterminingFtheFpatientsF mentalFstatusF isF
oneFpartF ofFtheF nursingF assessment,F butF itF isF notFtheFprimaryFpurpose.

DIF:FCognitiveFLevel:FComprehensionF
REF:FdmF36FOBJ:F1F|F3FTOP:FNursingF
ProcessFStep:FAssessment
MSC:FNCLEXF ClientFNeedsF Category:F HealthFPromotionFandF Maintenance

• WhatFisFtheFbasisFofFtheFNANDAFIF taxonomy?

A. FunctionalFhealthFpatterns
B. HumanFresponseFpatterns
C. BasicF humanF needs
D. PathophysiologicF needs

ANS:FB

TheF NANDAF IF taxonomyF identifiesF humanF responseF patterns.FFunction
alFcomponentsFofFhealthFpatternsFareFlimitedFtoFactivity,FfluidFvolume,Fnutr
ition,FselfFcare,FandFsensoryFperception.FBasicFhumanFneedsFcompriseFlessF
thanFmerelyFhealthFpatterns.F PathophysiologicFneedsF areFnotFpartFofFtheFsc
opeFofFNANDAFI.

, DIF:FCognitiveFLevel:FKnowledgeFRE
F:Fpp.F37-38FOBJ:F5FTOP:
NursingFProcessFStep:FDiagnosis
MSC:FNCLEXF ClientF NeedsF Category:FPhysiologicalF Integrity

• WhichFtaskFisFincludedF inFtheFassessmentFstepF ofFtheFnursingF process?

A. EstablishingF patientF goals/outcomes
B. ImplementingF theF nursingFcareFplanF (NCP)
C. MeasuringF goal/outcomeF achievement
D. CollectingFandF communicatingF data


ANS:FD

DataFareFcollectedFandFcommunicatedFinFtheFassessmentFphaseFofFtheFnursin
gFprocess.FEstablishingFgoalsFisFtheFfunctionFofFplanning.
ImplementingFtheFNCPFisFtheFfunctionFofFimplementation.FMeasuringFoutco
meFachievementFisFtheFfunctionFofFevaluation.

DIF:FCognitiveFLevel:FComprehensionF
REF:FdmF36FOBJ:F2F|F3FTOP:FNursingF
ProcessFStep:FAssessment
MSC:FNCLEXF ClientFNeedsF Category:F HealthFPromotionFandF Maintenance

• WhichFstatementFregardingF nursingFdiagnosesF isF accurate?

a. NursingFdiagnosesFremainFtheFsameF forFasF longFasFtheFdiseaseF isF present.
b. NursingF diagnosesF areFwrittenFtoFidentifyFdiseaseFstates.

c. NursingFdiagnosesFdescribeF patientFproblemsFthatF nursesF treat.
d. NursingFdiagnosesF identifyFcausesF relatedFtoFillness.


ANS:FC

DiagnosticFstatementsFidentifyFproblemsFaFnurseFisFindependentlyFableFtoFtr
eatFwithinFtheFscopeFofFprofessionalFpractice.FNursingFdiagnosesFvaryFwithF
theFchangingFconditionFofFtheFpatient.FTheFresponseFpatternsFareFuniqueFtoFt
heFpatientFandFareFnotFdiseaseFspecific.FNursingFdiagnosesFdescribeFtheFpati
entsFhumanFresponseFpattern.

DIF:F CognitiveF Level:F Comprehension